Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
4,763
+192
+4% +$41.3K 1.46% 17
2026
Q1
$994K Sell
4,571
-223
-5% -$49.5K 1.57% 20
2025
Q4
$1.1M Buy
+4,794
New +$1.09M 1.76% 19

Other funds holding ABBV

PCB Capital's ABBV Position: Q2 2026 in Review

PCB Capital increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $41.3K and bringing the position to 4,763 shares worth $1.2M. The position accounts for 1.46% of the portfolio, ranked #17.

PCB Capital first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,391 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PCB Capital held 4,763 shares of AbbVie worth $1.2M as of Q2 2026.
  • PCB Capital bought 192 AbbVie shares in Q2 2026, an estimated $41.3K.
  • AbbVie made up 1.46% of PCB Capital's portfolio in Q2 2026, its #17 holding.
  • PCB Capital first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 1,391 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PCB Capital's 13F filing for Q2 2026, filed 20 Jul 2026.